Current research shows that the combination of ellagic acid-hydroxyapatite combination is able to reduce the main proinflammatory cytokine of bone inflammation, TNF-α so that it can increase bone growth factors, BMP-4 and OPN, through IL-10. The gene discussed is IL10; the disease is inflammatory response.